FDA Issues Warning Letter to Inova Genomics
The agency’s letter warns the lab to cease illegally marketing genetic tests that claim to predict patients’ responses to specific medications.
Read MorePosted by Steve Halasey | Apr 4, 2019 | Research |
The agency’s letter warns the lab to cease illegally marketing genetic tests that claim to predict patients’ responses to specific medications.
Read MorePosted by Chaunie Brusie | Apr 3, 2019 | Culture Media, Software |
The test determines kidney glomerular filtration rate with an accuracy close to tracer-based plasma clearance measurements, but with the simplicity of a serum sample test.
Read MorePosted by Chaunie Brusie | Mar 11, 2019 | Culture Media, Software |
Emerging tools are harnessing the power of big data to improve healthcare
Read MorePosted by Chaunie Brusie | Feb 17, 2019 | Disease States |
The assay successfully distinguishes between active rejection and nonrejection, with high sensitivity and specificity.
Read MorePosted by Steve Halasey | Dec 12, 2018 | Compliance, Research |
Increasing preference for self-diagnosis continues to be a trigger for the sale of home-use diagnostics, but a wide variety of industry-specific and regulatory factors are influencing the strategies of market players.
Read More